MedTrace Logo

Effect of Prucalopride in Patients With Severe Chronic Idiopathic Constipation

NCT00576511 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2008-05-29

No results posted yet for this study

Summary

The purpose of this study is to determine whether prucalopride is safe and effective in patients with severe chronic constipation.

Conditions

  • Chronic Constipation

Interventions

DRUG

prucalopride

4 mg o.d.

DRUG

placebo

Placebo o.d.

Sponsors & Collaborators

  • Movetis

    lead INDUSTRY

Principal Investigators

  • Georges Coremans, MD · Department of Gastroenterology, University Hospital Gasthuisberg, Catholic University Leuven, Leuven

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1994-12-31
Primary Completion
1996-02-29
Completion
1996-02-29

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00576511 on ClinicalTrials.gov